Log in to your Inderes Free account to see all free content on this page.

Getinge

201.60 SEK

+0.25 %

Less than 1K followers

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+0.25 %

-9.35 %

-7.86 %

-2.66 %

-1.47 %

-4.95 %

-13.88 %

-10.36 %

+2,445.99 %

Getinge is a Swedish global medical technology company specializing in providing equipment and IT systems to the healthcare and life science industries. The company offers solutions for operating rooms, intensive care units, sterilization centers, and drug development, among other things. The company was founded in 1904 and is headquartered in Gothenburg.

Market cap

54.91B SEK

Turnover

54.03M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

21.4.

2026

General meeting '26

21.4.

2026

Interim report Q1'26

22.4.

2026

Annual dividend

All

Webcasts

Press releases

ShowingAll content types

Getinge, Audiocast, Q4'25

Webcast1/27/2026, 9:00 AM

Getinge, Audiocast, Q4'25

Regulatory press release1/27/2026, 7:00 AM

Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year

Press release1/22/2026, 1:30 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q4 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release1/13/2026, 7:00 AM

Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call

Regulatory press release12/18/2025, 8:00 AM

Camilla Sylvest is proposed for Getinge AB's Board of Directors

Getinge, Audiocast, Q3'25

Webcast10/21/2025, 8:00 AM

Getinge, Audiocast, Q3'25

Regulatory press release10/21/2025, 6:00 AM

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

Press release10/16/2025, 2:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2025

Press release10/13/2025, 8:00 AM

Getinge's Advanta V12 receives CE Mark for major bridging indications

Press release10/7/2025, 6:00 AM

Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call

Press release8/4/2025, 7:00 AM

Getinge: EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump

Getinge, Audiocast, Q2'25

Webcast7/18/2025, 8:00 AM

Getinge, Audiocast, Q2'25

Regulatory press release7/18/2025, 6:00 AM

Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

Press release7/15/2025, 12:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2025

Press release7/4/2025, 6:00 AM

Getinge invites fund managers, analysts, and media to Q2 Report 2025 conference call

Regulatory press release4/22/2025, 3:00 PM

Resolutions at Getinge's Annual General Meeting April 22, 2025

Getinge, Audiocast with teleconference, Q1'25

Webcast4/22/2025, 11:00 AM

Getinge, Audiocast with teleconference, Q1'25

Regulatory press release4/22/2025, 10:00 AM

Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward

Press release4/16/2025, 1:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q1 2025

Press release4/8/2025, 7:00 AM

Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.